bluebird bio, Inc. Quarterly Marketable Securities, Current in USD from Q3 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
bluebird bio, Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2014 to Q4 2023.
  • bluebird bio, Inc. Marketable Securities, Current for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$67.3M -100% Dec 31, 2023 10-K 2024-09-13
Q3 2023 $8.95M -$64.2M -87.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $72.4M +$21.4M +42% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $79.2M -$26.1M -24.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $67.3M -$71M -51.3% Dec 31, 2022 10-K 2024-09-13
Q3 2022 $73.2M -$302M -80.5% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $51M -$435M -89.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $105M -$467M -81.6% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $138M -$281M -67% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $375M -$531M -58.6% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $486M +$136M +38.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $573M +$8.67M +1.54% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $420M -$360M -46.2% Dec 31, 2020 10-K 2022-03-04
Q3 2020 $906M +$26.6M +3.02% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $351M -$622M -64% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $564M -$536M -48.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $779M -$203M -20.7% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $880M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $973M +$230M +30.9% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.1B +$435M +65.4% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $983M +$451M +84.9% Dec 31, 2018 10-K 2020-02-18
Q2 2018 $743M +$334M +81.6% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $665M +$247M +59.1% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $532M +$106M +24.9% Dec 31, 2017 10-K 2019-02-21
Q3 2017 $491M +$135M +37.9% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $409M +$55.9M +15.8% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $418M +$57.6M +16% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $425M +$71.8M +20.3% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $356M +$65.9M +22.7% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $353M +$136M +62.6% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $361M +$159M +78.7% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $354M +$228M +181% Dec 31, 2015 10-K 2017-02-22
Q3 2015 $290M +$164M +131% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $217M Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $202M Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $126M Dec 31, 2014 10-K 2016-02-25
Q3 2014 $126M Sep 30, 2014 10-Q 2014-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.